Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.

On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

WASHINGTON (AP) — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots ...

The More the Merrier, a new original Hallmark movie, features Abbott HeartMates, a program that provides support for people impacted by heart health challenges. The movie is set to premiere during ...

NEW YORK/LONDON (Reuters) -The Pfizer and Novo Nordisk battle for obesity drug developer Metsera intensified on Thursday ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate access for millions of American adults and children.Pfizer said in a release its vaccine is now ...